What Is the Patent Cooperation Treaty (PCT)?
If you’ve spent any time looking into filing a patent application, you’ve no doubt come across information about “the PCT.” It can be confusing, and it is often not well-understood. The Patent Cooperation Treaty (PCT) is an international agreement that lets an applicant file a single patent application and preserve the right to seek patents in more than 150 countries.
It does not create a single worldwide patent, and it does not grant patents at all. What it does is centralize the early stages of international filing and buy a company time before it has to commit money to individual countries.
For companies expanding into global markets, that time is often the difference between a smart international filing strategy and an expensive guess made too early.
This guide explains what the PCT is, how the process works step by step, where its real value lies, and how to decide whether it fits your situation. If you are weighing an international filing and want to talk it through for your own invention, call NK Patent Law at (919) 348-2194 or contact us online.
Why international patent protection is harder than it looks
Patent rights are territorial. A U.S. patent stops competitors in the United States and nowhere else. A company that wants protection in Europe, Japan, South Korea, Canada, or anywhere else has to pursue rights in each of those places, under each country’s own law.
Under the Paris Convention, an applicant who files a first application in one country has 12 months to file corresponding applications elsewhere while still claiming the benefit of that first filing date (the “priority date”).
Twelve months is not much time. Within a year of a first filing, most companies do not yet know which markets will matter, whether the product is commercially viable, or whether the next funding round will close.
Filing directly in a dozen countries at the 12-month mark is expensive, and a lot of that money is often spent before a company has the information it needs to spend it wisely. Each country generally will require separately paying translation fees, filing fees, and local patent attorneys in that country. As the number of countries grows, so does the cost.
The PCT exists to solve these problems.
Our attorneys hold engineering and science degrees and focus on patent prosecution and intellectual property strategy for technology-driven companies.
What the PCT actually gives you
Filing a PCT application within the 12-month window generally pushes the deadline for committing to individual countries out to 30 months from the priority date — and 31 months in some patent offices, including the European Patent Office, India, South Korea, and Australia. Instead of having to make the decision on which specific countries to pursue at the 12-month mark, a single PCT application gives you an additional 18 months to make those decisions.
That additional 18 months is the central benefit. It lets a company defer its largest international costs until it has more data about the technology, the market, and its funding.
As of May 2026, 158 countries are PCT contracting states, including nearly every major economy a technology company is likely to care about.
The most important thing to understand is what the PCT is not. There is no single “international patent” or “world patent.” At the end of the PCT process, an applicant still has to enter the “national phase” in each country where protection is wanted, and each patent office independently examines and grants (or refuses) the application under its own law.
It’s more accurate to think of the PCT as a runway, rather than as a destination.
Our attorneys hold engineering and science degrees and focus on patent prosecution and intellectual property strategy for technology-driven companies.
Call NK Patent Law at (919) 348-2194 or contact us online to discuss your patent strategy.
How the PCT process works, step by step
The process unfolds in two broad phases: the international phase, which is centralized, and the national phase, which is country-by-country.
1. Priority application
Most U.S. companies begin with a U.S. provisional or non-provisional application. Because the United States operates under a first-inventor-to-file system, securing an early, well-documented filing date matters. That first filing establishes the priority date that the entire international family will later claim priority to. This is often referred to as the priority application.
2. Filing the PCT application
Within 12 months of the priority application, the applicant files a single PCT application. For U.S.-based applicants, it can be filed with the United States Patent and Trademark Office (USPTO) acting as a Receiving Office, or directly with the International Bureau of the World Intellectual Property Organization (WIPO).
One application, in one language, with one set of fees, preserves filing rights across all 158 contracting states. There is no need to choose specific countries at this stage.
3. International Search Report and Written Opinion
An International Searching Authority (the USPTO and the European Patent Office are common choices for U.S. applicants) searches the prior art and issues an International Search Report along with a Written Opinion on whether the claimed invention appears novel, involves an inventive step, and is industrially applicable
This is one of the most undervalued features of the PCT. Long before a company spends money entering individual countries, it gets an expert read on how patentable the invention looks. That early assessment can shape claim strategy and inform investment decisions. In other words, you will have the knowledge of the prior-art references that were found and the written opinion before you have to make decisions on which specific countries to pursue. That means that you’re more informed before spending the significant costs associated with filing in each country.
4. International publication
At 18 months from the priority date, WIPO publishes the application. Publication puts the invention into the public record worldwide and can, in some jurisdictions, support provisional rights against later infringers once a patent issues.
5. Optional preliminary examination
An applicant who wants to refine the application can file a “Demand” for international preliminary examination. This produces an International Preliminary Report on Patentability and gives the applicant a chance to amend claims before reaching the national phase. It is optional, and whether it is worth the added cost depends on the situation.
6. National phase entry — the decision point
This is where the runway ends. By the 30-month deadline (31 in some offices), you must enter the national or regional phase in each jurisdiction where you want protection. This is where you pay the country-specific fees, including filing fees, translation fees, and local patent attorneys.
From this point forward, each patent office examines the application under its own law. The USPTO examines national-stage applications under 35 U.S.C. § 371.
Miss the national phase deadline in a given country, and the application is normally treated as withdrawn there. These deadlines are unforgiving, and they sit at the center of every international patent docket.
What the PCT does not do
This is one of the most commonly misunderstood aspects of the PCT.
The PCT does not give you a granted patent, an enforceable right anywhere on its own, or a way to avoid the eventual cost of national-phase prosecution. It defers those costs; it does not eliminate them.
A company should plan for the national phase as the point where the real expense arrives — translations, national filing fees, and local prosecution in each country.
Is the PCT always the right choice?
Not always.
The PCT is a strong fit for companies that expect to seek protection in several countries, that benefit from more time to assess markets and funding, and that want an early patentability read before committing capital.
For a company that already knows it wants protection in just one or two specific countries, filing directly in those countries under the Paris Convention within the 12-month window can sometimes be faster and less expensive overall, because it skips the international-phase fees.
The right answer depends on how many jurisdictions are realistically in play, how settled the commercial strategy is, and how the timing lines up with the company’s funding and product roadmap. This is a strategy question, and it will differ for everybody.
How the PCT fits into a broader IP strategy
A PCT application is rarely a standalone decision.
U.S.-based companies often adopt something of a “hybrid” approach, where they file both a U.S. application and a PCT application at the 12-month mark. The U.S. application is usually filed as a “Track One” application, which accelerates the speed of prosecution significantly. This allows the company to have the content of the patent application fully examined by the USPTO well before the filing decisions for foreign countries need to be made. In some cases, they may have received an issued patent in the U.S. before the foreign filing decisions arrive. This strategy provides valuable information about patentability as tested in the U.S., which can then be used for later decisions on both where to file and how to prosecute those later foreign filings.
In addition, continuation strategy in the United States can run in parallel with international filings, keeping a patent family open as the technology evolves. A well-thought-out view of which markets matter, and where competitors manufacture, sell, and operate, should drive the decision on which national-phase countries are worth the cost. Freedom-to-operate considerations in key markets may be just as important as securing your own rights.
For companies whose international plans also involve brand protection, trademark filing abroad runs on a separate but parallel track through mechanisms like the Madrid Protocol. The two systems are distinct, but they often need to be coordinated so deadlines do not collide and budgets are planned together.
How NK Patent Law approaches international filings
At NK Patent Law, international filing is treated as a strategic decision tied to business outcomes, not a procedural step.
We have helped clients coordinate international patent filings through the PCT and direct foreign routes, drawing on our patent prosecution practice and working alongside trusted foreign associates in the national-phase countries where local representation is required. Our patent attorneys and patent agents hold engineering and science degrees, which means the technical substance of an application (the part that ultimately determines whether claims survive examination in the United States and abroad) is handled by people who understand the underlying technology.
Our team has helped secure 2,100+ issued patents and 1,000+ registered trademarks for clients, with work spanning 36 U.S. states and 27 countries. That work covers software and machine learning, wireless communications, semiconductors and electronics, digital image processing, mechanical and electromechanical systems, chemistry, biotechnology, and renewable energy. Where a matter calls for specialized local counsel in a foreign jurisdiction, we coordinate that work rather than overstate our own role in it.
In practice, that means helping clients decide whether the PCT route fits, choosing a searching authority, managing the priority and national-phase deadlines that drive an international docket, and aligning the international filing plan with the company’s commercial strategy.
NK Patent Law has been recognized by Legal 500 U.S. Elite, Best Lawyers in America for Intellectual Property, Business North Carolina Legal Elite, and the Chambers USA Regional Spotlight Guide.
Speak with a patent attorney
If you are an inventor or a technology company weighing international patent protection, NK Patent Law would be glad to talk through whether the PCT route fits your situation and how the timing and cost would work for your invention.
Call NK Patent Law at (919) 348-2194 or contact us online to discuss your international patent strategy.